Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancerStefan Holdenrieder, Dorothea Nagel, Petra Stieber
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 7, 2004
The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (Plasmat Futura) in comparison with the currently used system (Plasmat Secura)Frithjof Blessing, Ying Wang, Dorothea Nagel, et al.
Anticancer Research|July 2, 2010
Long-term stability of circulating nucleosomes in serumStefan Holdenrieder, Joachim Von Pawel, Dorothea Nagel, et al.
BMJ Open|May 6, 2014
Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric studyChristine Prell, Dorothea Nagel, Folke Freudenberg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 12, 2012
Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapyNikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Shock (Augusta, Ga.)|May 18, 2005
Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot studyStefan Bengsch, Karl-Siegfried Boos, Dorothea Nagel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 7, 2013
Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapyJulia Lehner, Oliver J Stötzer, Debora Fersching, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 15, 2006
Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormoneChristian J Thaler, Helen Budiman, Heike Ruebsamen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 26, 2016
Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3Dorit Di Gioia, Irene Blankenburg, Dorothea Nagel, et al.
BMC Cancer|May 28, 2011
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patientsNikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Pageof 8